As previously reported, several miRNAs (miR-548-3p (Chen et al., 2019), miR-422a (Zhang et al., 2018a), and miR-217 (Zhang et al., 2015)) were shown to inhibit osteosarcoma by targeting KRAS. Here, KRAS is linked to osteosarcoma.